Medical Innovation Exchange

Hunting for cash, Jounce sells remaining stake in tumor antibody to partner Gilead for $67M

https://www.fiercebiotech.com/biotech/hunting-cash-jounce-sells-remaining-stake-promising-tumor-antibody-partner-gilead

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!